Introduction
Severe acute respiratory syndrome (SARS) was fi rst reported as an atypical pneumonia in Gangdong, China, in November 2002 [1] . The epidemic expanded rapidly to 26 regions and countries [2] [3] [4] , and by the end of July 2003, 8,098 probable cases had been reported and more than 774 people had died [5] . Although the epidemic seemed to be controlled during the summer of 2003, laboratory-associated infections appeared in Singapore in September 2003, in Taiwan Therefore, it must be considered possible that SARS outbreaks could start at any time, anywhere in the world.
In March 2003, a distinct coronavirus was identifi ed as the causative agent of SARS and designated as SARS coronavirus (SARS-CoV) [6] [7] [8] . SARS-CoV is an enveloped virus with a single positive-stranded RNA genome, for which the genome organization has been characterized [9] . Because SARS-CoV was isolated or identifi ed in Himalayan palm civets (Paguma larvata) and raccoon dogs (Nyctereutes procyonoides) , SARS appears to have a zoonotic origin [10] . However, the defi nitive animal reservoir for human cases of SARS-CoV has not yet been determined, and no effective vaccines or antiviral drugs have yet been developed.
Given this situation, the initial infection control effort in healthcare, home and community settings is crucially important to minimize the occurrence and spread of epidemics. The WHO laboratory network for SARS diagnosis reported preliminary data concerning the stability and resistance of the virus [11] . The virus seems to be susceptible to inactivation by heating and exposure to organic chemicals that disrupt the virus envelope, such as acetone and ethanol, as well as fi xatives such as formalin. However, additional information on inactivation of SARSCoV is imperative for the establishment of effective infection control protocols in a variety of settings. As several SARS outbreaks may have originated from laboratories, the guidelines for handling the virus in the laboratory must be established according to accurate information on the stability of SARS-CoV.
Povidone-iodine (PVP-I) products have been used for the disinfection of various bacteria and viruses for years because of their strong bactericidal and antiviral activities. If reliable data confi rm the effi cacy of PVP-I for the elimination of SARS-CoV infectivity, these products will become extremely useful for the destruction of the virus in various settings.
In this paper we evaluated the antiviral effi cacy of PVP-I against SARS-CoV; we also evaluated the antiviral effi cacy of various physical and chemical inactivation conditions.
Materials and Methods

Virus and Cells
The Hanoi strain of SARS-CoV was kindly provided by Dr. Koichi Morita, of Nagasaki University. The virus was propagated in Vero E6 cells, cultured in minimum essential medium (MEM), containing 10% fetal bovine serum. Virus stocks were prepared by collecting the culture supernatants from infected cells 48 h after infection, centrifuging the fl uid at 2,000 rpm for 10 min and storing the clarifi ed supernatants at -80 ° C until use. The mixtures were incubated for 1 min at room temperature and then diluted tenfold with sodium thiosulfate (0.5%) to neutralize the cytotoxicity and antiviral activity of PVP-I. The mixtures were serially diluted in MEM and 0.1-ml aliquots were inoculated onto Vero E6 monolayers in 96-well plates. The cells were incubated for 48 h in a CO 2 incubator and the cytopathic effect was observed under a microscope. The 50% tissue culture infectivity dose (TCID 50 /ml) remaining in the virus-disinfectant mixture was determined by the method of Reed and Muench [12] . The antiviral effi cacy of ethanol (70%) was evaluated in the same manner, except for the addition of MEM to dilute the mixture, rather than sodium thiosulfate.
Evaluation of the Antiviral Activity of PVP-I Products against SARS-CoV
Inactivation of Infectivity of SARS-CoV-Infected Vero E6 Cells by Chemical Reagents
Vero E6 cells grown in a 75-cm 2 fl ask were infected with SARSCoV and cultured for 48 h in a CO 2 incubator. By 48 h after infection, most of the cells had detached from the substrate, due to the development of a strong cytopathic effect. These fl oating cells were collected with the medium and centrifuged at 2,000 rpm for 10 min. The cell pellet was resuspended in 2 ml of MEM and 0.5-ml aliquots of this cell suspension were distributed into cryogenic vials. After an additional centrifugation, the supernatant was removed and the cell pellets were stored at -80 ° C to be used as the stock of infected Vero E6 cells.
The infected cells were thawed and suspended in 100% acetone, 100% methanol, 3.5% paraformaldehyde or 2.5% glutaraldehyde for various times. The cells suspended in acetone were held at -10 ° C in a freezer. The cells suspended in the other reagents were held at room temperature. After the treatment, the cells were collected by centrifugation, washed with phosphate-buffered saline and suspended in 1 ml MEM. The serially diluted cells were inoculated onto Vero E6 cells grown in fl at-bottom 96-well plates, and the remaining infectivity was determined by the TCID 50 method. Normal uninfected Vero E6 cells were also incubated with the fi xatives and inoculated onto Vero E6 monolayers to see the cytotoxicity caused by the fi xed cells.
Physical Inactivation of SARS-CoV
For the evaluation of heat inactivation, aliquots of the virus stock were placed in 50-ml tubes and heated at 56 ° C in a water bath for various times. The temperature in the tubes was monitored with a thermometer placed in the same amount of MEM in a separate tube. To evaluate the effi cacy of ultraviolet (UV) irradiation, 2-ml aliquots of stock virus were placed in open 3-cm plastic Petri dishes, positioned under the UV light source in a biosafety cabinet and irradiated with 134 W/cm 2 for various times. The treated virus stocks were serially diluted in U-bottom 96-well plates, and 100-l aliquots of diluted virus were inoculated onto monolayers of Vero E6 cells in 96-well plates and cultured for 48 h in a CO 2 incubator. The cytopathic effect was observed under a microscope. , respectively. However, treatment with all the PVP-I products for 2 min completely inactivated the virus. The treatment of 70% ethanol for 1 min also reduced the virus infectivity under the detectable level ( ! 10). These results strongly indicate that PVP-I products and 70% ethanol are effective for the inactivation of SARS-CoV.
Results
Effi cacy of PVP-I on SARS-CoV
Fixation of Cells Infected with SARS-CoV by Chemical Reagents
To determine the stability of SARS-CoV treated with several chemical reagents usually used as laboratory fi xatives, Vero E6 cells infected with SARS-CoV were suspended in fi xatives including formalin, glutaraldehyde, methanol and acetone. The cells were treated with the fi xatives, washed with phosphate-buffered saline and overlaid onto Vero E6 monolayers to evaluate the remaining infectivity. After treatment with any of the fi xatives for 5 min or longer, no infectivity remained in the cells ( table 2 ) . Therefore, SARS-CoV-infected cells can be effectively inactivated by these chemical reagents.
Physical Inactivation of SARS-CoV
We tested the resistance of SARS-CoV to physical treatments such as heating and UV irradiation. Aliquots of virus were heated at 56 ° C for various times and the kinetics of virus inactivation were analyzed. Heating for 5 min rapidly inactivated the virus infectivity from 2.6 ! 10 7 to 40 TCID 50 /ml ( fi g. 1 ). Only low infectivity ( ! 10 TCID 50 /ml) remained after heating for 30 min. After 60-min and 90-min treatments with heat, no virus infectivity was detected. When SARS-CoV was irradiated under normal biosafety cabinet UV lights, the virus titer was reduced from 3.8 ! 10 7 to 180 TCID 50 /ml in 15 min, but the virus was still detected (18.8 TCID 50 / ml), even after 60 min of irradiation ( fi g. 2 ). These results indicate that SARS-CoV is relatively resistant to UV irradiation. 
Discussion
We tested the effi cacy of several PVP-I products, including Isodine, Isodine Scrub, Isodine Palm, Isodine Gargle and Isodine Nodo Fresh, all of which cover a variety of disinfection applications; these applications include disinfecting medical instruments and skin as well as hand-washing, gargling and spraying the throat. The results clearly indicate that all the PVP-I products tested have strong virucidal activities against SARS-CoV. Because SARS-CoV is believed to be transmitted mainly through the airborne route [13] , PVP-I products for gargling and spraying the throat may have a prophylactic effect on SARS during outbreaks. Since the virus is also shed into feces and urine [14, 15] , scrubbing hands with PVP-I may be effective in hospitals and households, especially after contact with SARS patients and after handling the clothes or linen of the patients.
Chemical reagents, heating and UV irradiation are the common means of inactivating pathogens. SARS-CoVinfected cells were effectively inactivated by treatment with cold acetone, methanol, formalin and glutaraldehyde for 5 min or longer. Therefore, infected cells can be safely handled after fi xation with these common reagents. The results of indirect fl uorescent antibody assays indicated that the antigenicity of SARS-CoV in infected cells is restored after treatment with acetone and methanol (data not shown). SARS-CoV was completely inactivated by heating at 56 ° C for 60 min or longer. The virus nucleocapsid protein was detected in the supernatant of infected cells by Western immunoblotting after heating at 56 ° C for 90 min (data not shown). Therefore, prolonged heating would be a useful method of safely preparing samples for laboratory diagnostic tests. Residues of virus on laboratory benches can be inactivated by UV irradiation, but the effi cacy is incomplete. The combination of spraying and wiping the bench with 70% ethanol, followed by UV irradiation may completely inactivate any virus on the bench.
We believe that the results of this study will be useful in the control of SARS and for establishing guidelines for the safe handling of live virus in the laboratory, thus preventing SARS outbreaks of laboratory origin. 21st Century COE Program, 'Program of Excellence for Zoonosis Control', Ministry of Education, Science, Sports and Culture. Fig. 1 . Kinetics of SARS-CoV inactivation by heating. Aliquots of SARS-CoV were heated in a 56 ° C water bath for the indicated times. The heated virus aliquots were serially diluted and inoculated onto monolayers of Vero E6 cells grown in 96-well plates. After incubation for 48 h, the cytopathic effect in the cells was observed and the infectivity was determined by the TCID 50 method. Fig. 2 . Kinetics of SARS-CoV inactivation by UV irradiation. Aliquots of SARS-CoV were irradiated with UV light for the indicated times. The irradiated virus aliquots were serially diluted and inoculated onto monolayers of Vero E6 cells grown in 96-well plates. After incubation for 48 h, the cytopathic effect in the cells was observed and the infectivity was determined by the TCID 50 method.
